516
Participants
Start Date
March 31, 2012
Primary Completion Date
May 31, 2013
Study Completion Date
August 31, 2013
Deoxycholic acid injection
Formulated as an injectable solution containing deoxycholic acid at a concentration of 10 mg/mL.
Placebo
Phosphate buffered saline placebo for injection
Investigational Site, New York
Investigational Site, New York
Investigational Site, White Plains
Investigational Site, Lutherville
Investigational Site, Charlottesville
Investigational Site, High Point
Investigational Site, Charlotte
Investigational Site, Jacksonville
Investigational Site, Coral Gables
Investigational Site, Cincinnatti
Investigational Site, Carmel
Investigational Site, South Bend
Investigational Site, Clinton Township
Investigational Site, Edina
Investigational Site, Naperville
Investigational Site, Chicago
Investigational Site, St Louis
Investigational Site, Little Rock
Investigational Site, Plano
Investigational Site, San Antonio
Investigational Site, Austin
Investigational Site, Englewood
Investigational Site, Salt Lake City
Investigational Site, Los Angeles
Investigational Site, Beverly Hills
Investigational Site, Santa Monica
Investigational Site, San Francisco
Investigational Site, Sacramento
Investigational Site, Portland
Investigational Site, Montclair
Investigational Site, Calgary
Investigational Site, Surrey
Investigational Site, Vancouver
Investigational Site, Oakville
Investigational Site, Woodbridge
Lead Sponsor
Kythera Biopharmaceuticals
INDUSTRY